UAE Pharmaceutical Market Report 2022: Expanding Healthcare Infrastructure to Boost Sector Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 4, 2022--

The "UAE Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.

The UAE pharmaceutical market is projected to grow at a formidable rate during the forecast period, 2023-2027. The market growth can be attributed to the expanding healthcare infrastructure in the country and high investments by market players in developing effective drugs and medicines. Besides, rising incidences of chronic disorders such as diabetes, cardiovascular diseases, renal disorders, and infectious diseases are expected to propel the growth of the UAE pharmaceutical market in the coming years.

The government of the United Arab Emirates is actively working to advance the pharmaceutical sector. Due to its potential for future growth, export potential, and medium- to long-term economic effect, the pharmaceutical industry is a target of initiatives such as the Dubai Industrial Strategy 2030 and the Abu Dhabi Vision 2030.

The country's pharmaceutical needs were largely satisfied by imported medications and pharmaceutical goods. Through increased investments in the research and development of pharmaceutical and therapeutic products, the nation is actively working to reduce the import of pharmaceuticals and manufacture related products in the future.

The government is establishing relationships with major international market participants to enhance its production of pharmaceutical items. With favorable funding, distribution channel plans, strategic planning, and a highly developed logistics infrastructure, the UAE pharmaceutical business is expected to grow over the next five years.

The country's pharmaceutical industry is expanding due to the rising incidence of chronic diseases, infectious diseases, and lifestyle disorders. Chronic conditions like cancer, neurological illnesses, and cardiovascular diseases are propelling the market's expansion. Both male and female residents of the nation were found to have 4,807 new instances of cancer.

The increased demand for pharmaceutical products was helped by infectious disorders brought on by increased tourism, environmental factors, and the most recent viral infection brought on by COVID-19. The government also supported the idea by increasing investment in the sector. Disrupted import routes have forced pharmaceutical companies to manufacture pharmaceuticals in the country.

Key Target Audience:

• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, UAE pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

UAE Pharmaceutical Market, By Drug Type:

• Generic Drugs
• Branded Drugs

UAE Pharmaceutical Market, By Product Type:

• Prescription Drugs
• Over-The-Counter Drugs

UAE Pharmaceutical Market, By Application:

• Cardiovascular
• Musculoskeletal
• Oncology
• Anti-infective
• Metabolic Disorder
• Others

UAE Pharmaceutical Market, By Distribution Channel:

• Retail Pharmacy
• Hospital Pharmacy
• E-Pharmacy

UAE Pharmaceutical Market, By Region:

• Dubai Region
• Sharjah Region
• Abu Dhabi Region
• Rest of UAE

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on UAE Pharmaceutical Market

5. Voice of Customer

6. UAE Pharmaceutical Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

6.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5. By Region

6.2.6. By Company (2021)

6.3. Product Market Map

7. UAE Generic Drugs Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Application

7.2.3. By Distribution Channel

8. UAE Branded Drugs Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Application

8.2.3. By Distribution Channel

9. Market Dynamics

9.1. Drivers

9.2. Challenges

10. Market Trends & Developments

11. Policy & Regulatory Landscape

12. UAE Economic Profile

13. Competitive Landscape

14. Strategic Recommendations

Companies Mentioned

• Julphar Gulf Pharmaceutical Industries
• Bayer Consumer Health
• Lifepharma FZE
• Niner Pharmaceuticals LLC
• GlaxoSmithKline & Neopharma
• Pfizer UAE
• Johnson & Johnson Middle East FZ-LLC

For more information about this report visit https://www.researchandmarkets.com/r/c059hx

View source version on businesswire.com:https://www.businesswire.com/news/home/20221004005634/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: MIDDLE EAST UNITED ARAB EMIRATES

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2022.